Weight loss injections have rapidly transformed the British approach to tackling obesity, with an extraordinary surge in private usage. Latest data suggests that 2.5 million adults in the UK—one in
Weight loss injections have rapidly transformed the British approach to tackling obesity, with an extraordinary surge in private usage. Latest data suggests that 2.5 million adults in the UK—one in
Eli Lilly, the US manufacturer of the weight management injection Mounjaro, has announced a new discount for private pharmacies in the UK. The move follows widespread concern after the company
Eli Lilly, the pharmaceutical giant behind the popular weight loss injection Mounjaro, has announced a substantial price hike for the medication due to take effect in the UK from September.
The UK market for private weight loss drugs is bracing itself for seismic change as Eli Lilly announces dramatic price increases for its popular Mounjaro injections. Over 1.5 million Britons
A major rise in the cost of Mounjaro is set to impact more than a million weight loss patients across Britain next month amid an international dispute over medicine prices.
In a remarkable feat, Eli Lilly’s weight-loss drug Zepbound has surpassed 1 billion in sales for the first time, exceeding Wall Street’s expectations. The American pharmaceutical giant also saw strong






